crohn's disease and glp-1 Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology The role of GLP-1 RA

Digital health platforms were already set up to prescribe online, ship medications directly to patients, drive patient engagement, and operate outside of traditional insurance systems

A recent study involving 3,390 people taking semaglutide or liraglutide found participants who took high doses of their drug 1.7 mg, 2.0 mg or 2.4 mg of semaglutide, or 3 mg of liraglutide lost more weight after a year compared to people taking lower doses

baseline, placebo and dulaglutide 1.5 mg

Los agonistas GLP-1 tienen un peso molecular muy alto (3,000-59,000 Daltons), lo que dificulta su penetracin a travs de la barrera cutnea

Joint hypermobility syndrome(JHS) Joint hypermobility syndrome is when one has very flexible joints because the joints are loose and stretchy when the ligaments that should make them stronger and support them are weak